Landos Biopharma, Inc.
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic c…
Biotechnology
US, Blacksburg [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Landos Biopharma, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDLandos Biopharma, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Landos Biopharma, Inc..
If you want to see a demo, head over to the financial segments of AAPL